biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Questions, No Answers - An Anecdote

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Aug 23, 2023 8:14pm

103 Views

Post# 35602946

RE:RE:Questions, No Answers - An Anecdote

Hey Uncle,

....if anything was remotely and I MEAM remotely that JD said in his last 2 mega posts ( yes JD I DID read the whole thing! Surprise) were correct I would think that those investors ( gamblers) with millions of shares would try to turn this thing around!

BUT just the opposite! SILENCE from everyone!

WHY do you think it's that way JD?

Don't you think these people would at least try?

Or could it be THEY are part of your conspiracy?

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports